We are excited to announce the promotion of Hayden Poer to Tax Manager. Congratulations, Hayden!
About us
SK Capital is a private investment firm with a disciplined focus on the specialty materials, ingredients and life sciences sectors. Our integrated, multi-disciplinary team utilizes its industry, operating and investment experience to transform businesses into higher performing organizations. SK Capital seeks buyouts, recapitalizations and growth equity investments. We target companies with opportunities for substantial business improvement, and through active engagement with management teams, we invest in the people and processes that drive our long-term strategic and financial goals.
- Website
-
http://www.skcapitalpartners.com
External link for SK Capital Partners
- Industry
- Financial Services
- Company size
- 51-200 employees
- Headquarters
- New York
- Type
- Privately Held
Locations
-
Primary
Get directions
430 Park Ave
New York, 10022, US
-
Get directions
1515 N. Federal Highway, Suite 405
Boca Raton, Fl 33432, US
Employees at SK Capital Partners
Updates
-
Last week, the SK Capital Catalyst team and CEOs of the Catalyst portfolio companies came together for a CEO Forum to share best practices, find ways to enhance collaboration, and further cultivate strong relationships between the CEOs and broader Catalyst team. The CEOs also had the opportunity to learn more about the SK Capital funds and our approach to investing. We were also joined by retired US Navy SEAL leader, Captain Bob Smith, who discussed topics such as acting with integrity as a leader, building trust, the importance of communication, and the experience of enduring hardship.
-
-
We are proud to support Apotex as they continue to grow within the specialty branded innovative pharmaceutical market.
Apotex is pleased to announce the successful completion of its acquisition of Searchlight Pharma Inc., a leading Canadian specialty innovative branded pharmaceutical company. This acquisition accelerates Apotex’s growth within the specialty branded innovative pharmaceutical market, reaffirming our commitment to delivering high-quality, innovative solutions to patients and consumers around the world. Searchlight is now operating as the Specialty Pharma Division of Apotex. Learn more here: https://bit.ly/4aN6mKo
-
-
Today marks the 50th anniversary of Apotex Inc., the largest Canadian-based pharmaceutical company. Established on May 24, 1974, Apotex has grown from a two-employee, Toronto-based operation to a global leader in the generics industry, represented by its top position in the number of prescriptions produced, diverse portfolio of products, and significant and complex manufacturing capabilities. In addition to being a leader in product launches and opening markets around the world, Apotex has been deeply involved in leading-edge healthcare philanthropy, donating to thousands of organizations – big and small – as part of its commitment to improving access to medicines worldwide. We are proud to support Apotex’s mission to provide innovative and affordable medicines to all patients.
-
-
SK Capital Partners reposted this
SK Capital is pleased to announce the sale of Foremark.
-
SK Capital is pleased to announce the sale of Foremark.
SK Capital Has Completed the Sale of Foremark to Affiliates of CC Industries
businesswire.com
-
SK Capital is pleased to announce the close of SK Capital Partners VI at $2.95bn of total commitments. SK Capital Partners VI will continue targeting transformative investments in the specialty materials, ingredients, and life sciences industries. We thank our investors and partners for their continued support and trust. Please see the link below for more information. https://lnkd.in/ed3vcUYX
-
-
Today marks the one-year anniversary of SK’s partnership with Apotex and we are excited to be celebrating Apotex’s next step in its growth journey!
We are excited to announce that Apotex has entered into an agreement to acquire Searchlight Pharma Inc., a leading Canadian specialty and innovative branded pharmaceutical company. Building on the recent transaction with Harrow, Inc., this acquisition further accelerates our growth within the specialty branded pharmaceutical market, positioning Apotex to become the partner of choice for pharmaceutical licensing and acquisition opportunities in the Americas. Read the full release here: http://bit.ly/3IZJ6NU
-
-
We are proud to continue building our relationship with SuitUp.
Join us in celebrating the 2nd Annual SuitUp with SK Capital Partners Competition! Last week, SK Capital volunteers coached teams of students from Fort Hamilton High School and Erasmus Academy through a custom event and the winning team walked away with a real cash prize. Check out what one of our student CEOs had to say about their experience!
-